4.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
30.37%
19.22
|
14.74 | 4.546 | 26.08 | 14.42 |
Cost Of Revenue |
7.64%
20.16
|
21.83 | 12.79 | 12.08 | 9.199 |
Gross Profit |
86.76%
-0.938
|
-7.084 | -8.248 | 14.00 | 5.218 |
|
4.88%
175.29
|
184.28 | 175.52 | 112.36 | 105.76 |
Benefits Costs and Expenses |
12.08%
191.12
|
217.39 | 183.44 | 121.76 | 112.48 |
Costs And Expenses |
5.17%
195.45
|
206.11 | 188.31 | 124.44 | 114.96 |
Operating Income/Loss |
7.91%
-176.23
|
-191.37 | -183.77 | -98.35 | -100.54 |
Nonoperating Income/Loss |
138.40%
4.33
|
-11.28 | 4.869 | 2.679 | 2.48 |
Income/Loss From Continuing Operations Before Tax |
15.17%
-171.90
|
-202.65 | -178.90 | -95.67 | -98.06 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.158 | 0.007 | 0.167 | -0.523 |
Income/Loss From Continuing Operations After Tax |
15.11%
-171.90
|
-202.49 | -178.91 | -95.84 | -97.54 |
|
15.11%
-171.90
|
-202.49 | -178.91 | -95.84 | -97.54 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.62%
417.36
|
402.77 | 20.76 | 282.58 | 242.20 |
Diluted Average Shares |
3.62%
417.36
|
402.77 | 20.76 | 282.58 | 242.20 |
Basic Earnings Per Share |
18.00%
-0.41
|
-0.50 | -0.57 | -0.34 | -0.40 |
Diluted Earnings Per Share |
18.00%
-0.41
|
-0.50 | -0.57 | -0.34 | -0.40 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):